OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 13D and 13G filings for Amryt Pharma plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 10:34 am Sale | 2021-12-31 | 13G | Amryt Pharma plc AMYT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 9,950,000 3.110% | -3,263,340 (-24.70%) | Filing |
| 2021-02-16 10:32 am Purchase | 2020-12-31 | 13G | Amryt Pharma plc AMYT | OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 13,213,340 7.300% | 13,213,340 (New Position) | Filing |